Phibro Animal Health (NASDAQ:PAHC) Shares Down 6.5% – Should You Sell?

Phibro Animal Health Co. (NASDAQ:PAHC)’s share price was down 6.5% on Wednesday . The company traded as low as $24.11 and last traded at $24.15. Approximately 162,313 shares traded hands during trading, a decline of 22% from the average daily volume of 207,590 shares. The stock had previously closed at $25.82.

Analyst Ratings Changes

Several research analysts have commented on the company. Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Finally, Morgan Stanley upped their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Stock Performance

The firm has a market cap of $978.89 million, a price-to-earnings ratio of 50.35, a PEG ratio of 0.50 and a beta of 0.52. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company has a 50 day moving average of $22.17 and a 200 day moving average of $21.99.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, equities research analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.99%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Phibro Animal Health during the 4th quarter valued at approximately $29,000. Lazard Asset Management LLC raised its holdings in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock worth $34,000 after purchasing an additional 1,589 shares during the period. Aquatic Capital Management LLC bought a new position in shares of Phibro Animal Health in the 4th quarter worth about $69,000. Virtus Fund Advisers LLC acquired a new position in shares of Phibro Animal Health in the 4th quarter valued at about $69,000. Finally, Quantbot Technologies LP bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $70,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.